The Provost; Fellows; Foundation Scholars; & the other members of Board; of the College of the Holy & Undiv. Trinity of Queen Elizabeth near Dublin
发明人:
申请号:
EP14160791.1
公开号:
EP2921178A1
申请日:
2014.03.19
申请国别(地区):
EP
年份:
2015
代理人:
摘要:
The present invention relates to Toll-Like Receptor 2 (TLR2) agonists, in particular, to TLR2-activating lipoproteins, and more particularly to TLR2-activating lipopeptides derived from the bacteria Bordetella pertussis. The invention further extends to the use of said TLR2-activating lipoproteins as a therapeutic or as part of a vaccine composition in the treatment and prevention of infectious diseases, cancer or allergic diseases.